Advances in developing tris(8-quinolinolato)gallium(iii) as an anticancer drug: critical appraisal and prospects
Abstract
Gallium-based anticancer chemotherapeutics are appreciably progressing in clinical studies. A steady interest of
* Corresponding authors
a
Vernadsky Institute of Geochemistry and Analytical Chemistry, Russian Academy of Sciences, Kosygin St. 19, Moscow, Russia
E-mail:
andrei.timerbaev@univie.ac.at
Gallium-based anticancer chemotherapeutics are appreciably progressing in clinical studies. A steady interest of
Fetching data from CrossRef.
This may take some time to load.
Loading related content